Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    Hereditary Breast and Ovarian Cancer | United States, Georgia
Show Display Options
Rank Status Study
1 Enrolling by invitation Identification and Referral of Women at Risk for Hereditary Breast/Ovarian Cancer
Condition: Hereditary Breast and Ovarian Cancer
Interventions: Other: Breast Cancer Genetics Referral Screening Tool 3.0;   Other: Standard Handout;   Other: Physician Notification;   Other: Automatic Follow-Up by Genetic Counseling Staff
2 Completed Veliparib, Carboplatin, and Paclitaxel in Treating Patients With Advanced Solid Cancer
Conditions: Adult Solid Neoplasm;   BRCA1 Mutation Carrier;   BRCA2 Mutation Carrier;   Hereditary Breast and Ovarian Cancer Syndrome
Interventions: Drug: Carboplatin;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel;   Other: Pharmacological Study;   Drug: Veliparib

Indicates status has not been verified in more than two years